Shyness: How Normal Behavior Became a Sickness

Christopher Lane. <i>Yale University Press. $27.50.</i>

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


“Shyness is nice, and shyness can stop you from doing all the things in life you’d like to,” Morrissey once sang. It’s a wonder that this classic Smiths song was never used in an ad for Paxil, the Prozac also-ran that GlaxoSmithKline successfully repurposed into a magic bullet for people with “social anxiety disorder,” a.k.a. shyness—now the third most common psychiatric disorder in America behind depression and alcoholism.

To explain how a once-ordinary affliction became a profitable disease, Christopher Lane offers a depressing yet fascinating behind-the-scenes look at the making of the bible of modern psychiatry, the Diagnostic and Statistical Manual of Mental Disorders. In the battle over the third revision of the DSM, released in 1980, neuropsychiatrists triumphed over their Freudian colleagues, implementing a radical new way of diagnosing mental problems—not as broadly defined neuroses, but as distinct disorders with specific symptoms. This seemingly scientific shift opened the door for dozens of new conditions, including one for people who “avoid going to parties”—virgin territory for pharmaceutical firms looking for niches for their existing products.

As Lane reminds us, this wasn’t the first time the drug industry eagerly prescribed psychopharmaceuticals to soothe the anxieties of everyday life. In the 1950s, tranquilizers were marketed to anxious housewives with no mention of risks or side effects. Jump to the present, in which the fda has loosened the restrictions on direct-to-consumer marketing: An ad for Zoloft asks, “Is she just shy? Or is it Social Anxiety Disorder?” Meanwhile, concerns about withdrawal from Paxil and similar antidepressants have been swept under the mat.

The desire to cure shyness isn’t just driven by greed; it’s also fed by basic human fears. Who hasn’t worried about messing up a speech or been tongue-tied on a date? But once you begin relying on drugs to regulate anxiety, Lane notes, unexpected bumps will come up. One of the conditions being considered for inclusion in the next version of the DSM is “apathy.” One reason? Turns out that “psychotropics are a very potent cause of it.”


If you buy a book using a Bookshop link on this page, a small share of the proceeds supports our journalism.

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with The Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with The Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate